Found: 13
Select item for more details and to access through your institution.
Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 449, doi. 10.1002/jcph.1999
- By:
- Publication type:
- Article
Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID‐19‐Associated Acute Respiratory Distress Syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Pharmacokinetics of Tropifexor, a Potent Farnesoid X Receptor Agonist, in Participants With Varying Degrees of Hepatic Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 520, doi. 10.1002/jcph.1996
- By:
- Publication type:
- Article
MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 463, doi. 10.1002/jcph.1995
- By:
- Publication type:
- Article
Population Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model‐Informed Dose Selection for Pediatric Development.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 555, doi. 10.1002/jcph.1990
- By:
- Publication type:
- Article
Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 541, doi. 10.1002/jcph.1987
- By:
- Publication type:
- Article
Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 532, doi. 10.1002/jcph.1984
- By:
- Publication type:
- Article
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 505, doi. 10.1002/jcph.1980
- By:
- Publication type:
- Article
Assessment of Transporter‐Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients With Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 494, doi. 10.1002/jcph.1979
- By:
- Publication type:
- Article
Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 486, doi. 10.1002/jcph.1978
- By:
- Publication type:
- Article
Time Above All Else: Pharmacodynamic Analysis of β‐Lactams in Critically Ill Patients.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 479, doi. 10.1002/jcph.1977
- By:
- Publication type:
- Article
Long‐Acting Lipoglycopeptides Can Interfere With Vancomycin Therapeutic Drug Monitoring.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 472, doi. 10.1002/jcph.1975
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 443, doi. 10.1002/jcph.1660
- Publication type:
- Article